Powered by
-
TMO Stock Chart
Historical TMO Prices
Thermo Fisher Scientific Stock Analysis
Rating: Hold
Total Grade: C
Analysis Breakdown
| TMO Stock Grade: | C |
| Fundamental Grade: | C |
| Quantitative Grade: | C |
| TMO Earnings | |
| Earnings Growth: | D |
| Earnings Momentum: | F |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | C |
| TMO Financial Information | |
| Sales Growth: | B |
| Operating Margin Growth: | D |
| Cash Flow: | C |
| Return on Equity: | C |
Thermo Fisher Scientific Stock: Weekly View
| This Week: | C |
|---|---|
| Last Week: | C |
| Two Weeks Ago: | C |
TMO Stock predictions, Articles, and Thermo Fisher Scientific News
- From InvestorPlace
- From the Web
-
7 Stocks on a Long-Term Uptrend - April 17, 2018
Looking for some stocks to buy that you don't have to babysit? These names are in a bullish groove that looks secure enough. Continue…
-
The 10 Best Stocks to Buy for April - April 3, 2018
Add these names to a list of stocks to buy sooner rather than later. Between seasonality and news, these tickers could buck the marketwide bearish trend. Continue…
-
The 10 Most Expensive Stocks In The S&P 500 - January 24, 2018
These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware. Continue…
-
Thermo Fisher Scientific (TMO) a Buy on Superior Sales Growth - December 7, 2017
Thermo Fisher Scientific Inc (NYSE:TMO) is ranked as a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. TMO has maintained this ranking for 2 months. Continue…
-
Thermo Fisher Scientific (TMO) Ranking Raised to Buy on Strong Earnings Growth - November 30, 2017
Thermo Fisher Scientific Inc (NYSE:TMO) is ranked as a Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical. Continue…
-
Thermo Fisher Scientific (TMO) Upgraded to Buy from a Hold - November 23, 2017
The current recommendation of Buy for Thermo Fisher Scientific Inc (NYSE:TMO) is derived using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical. Continue…
-
Sagging Quant Score Downgrades Thermo Fisher Scientific (TMO) to Hold - November 16, 2017
Thermo Fisher Scientific Inc (NYSE:TMO) ranks in the top 10% of its industry group, Life Sciences Tools & Services, and in the top 10% of its sector group, Health Care, with a market value of $74.7 billion. From an investment attractiveness prospective, TMO is ranked in the top half of the sector with a ranking of 311 among the 782 companies in the sector; the ranking for TMO by Portfolio Grader places it 20 among the 33 companies in this industry group, giving it a lower than average position and number 1,957 in the 5000 company Portfolio Grader company universe. Continue…
-
7 Life Science Stocks to Buy Today - November 14, 2017
You should buy the dip in life science stocks because their long-term futures are assured. Here are seven to pick up today. Continue…
-
Earnings Visibility Keep Thermo Fisher Scientific (TMO) a Buy - November 9, 2017
Thermo Fisher Scientific Inc (NYSE:TMO) is one of the 785 companies in the GICS Health Care sector, and a constituent of the 33 company Life Sciences Tools & Services GICS industry group within this sector. The market value of TMO is $77.7 billion which falls in the top 10% of its industry group. The ranking for TMO by Portfolio Grader places it 17 among the 33 companies in this industry group, giving it a below-average spot; in the top half of the sector with a ranking of 234 among the 785 companies in the sector, and number 1,518 in the nearly 5,000 company Portfolio Grader universe. Continue…
-
Quant Score Makes Thermo Fisher Scientific (TMO) a Buy - November 2, 2017
Portfolio Grader currently ranks Thermo Fisher Scientific Inc (NYSE:TMO) a Buy. The methodology for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. TMO has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy. Continue…
